✕
Login
Register
Back to News
Sana Biotechnology Announces Oral Presentation Highlighting Preclinical Data From SG293 In Vivo CAR T Product Candidate At American Society Of Gene & Cell Therapy 2026 Annual Meeting May 11-15
Benzinga Newsdesk
www.benzinga.com
Neutral 93.2%
Neg 0%
Neu 93.2%
Pos 0%
Comments
No comments yet. Be the first!
Join the discussion
Login to comment
Login to comment